{"id":"NCT00096785","sponsor":"Bristol-Myers Squibb","briefTitle":"Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection","officialTitle":"Randomized, Open-Label, Comparative Study to Evaluate Early Viral Load Reductions and Exploratory Viral Kinetics Following Administration of Entecavir or Adefovir in Nucleoside-Naive Adults With Chronic Hepatitis B Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-12","primaryCompletion":"2006-01","completion":"2008-04","firstPosted":"2004-11-16","resultsPosted":"2010-01-06","lastUpdate":"2010-08-10"},"enrollment":69,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis B","Chronic Disease"],"interventions":[{"type":"DRUG","name":"entecavir","otherNames":["Baraclude"]},{"type":"DRUG","name":"adefovir","otherNames":[]}],"arms":[{"label":"A1","type":"ACTIVE_COMPARATOR"},{"label":"A2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate antiviral activity and efficacy of entecavir (ETV) compared to adefovir in adults with chronic hepatitis B who have not been treated yet with an antiviral medicine.","primaryOutcome":{"measure":"Change From Baseline in Hepatitis B Virus DNA (HBV DNA) by Polymerase Chain Reaction (PCR) Assay at Week 12","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"Entecavir","deltaMin":-6.23,"sd":0.247},{"arm":"Adefovir","deltaMin":-4.52,"sd":0.357}],"pValues":[]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":null},"locations":{"siteCount":24,"countries":["United States","Canada","Hong Kong","Indonesia","Philippines","Singapore","Taiwan","Thailand"]},"refs":{"pmids":["19065670"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":33},"commonTop":["HEADACHE","INFLUENZA","UPPER RESPIRATORY TRACT INFECTION","COUGH","NASOPHARYNGITIS"]}}